-
Published19/01/2026
-
Today08/08/2026
-
Deadline28/12/2027
-
Opening of tenders28/12/2027
Utilities
- indicates text translated automatically in your browsing language
Conclusion of a non-exclusive discount agreement pursuant to §130c(1) SGB V / § 130a(8) SGB V for medicinal products containing the active substance cladribine (ATC: L04AA40).
Conclusion of a non-exclusive discount agreement pursuant to §130c(1) SGB V / § 130a(8) SGB V for medicinal products containing the active substance cladribine (ATC: L04AA40) within the period from 01.03.2026 to 29.02.2028 with the possibility of concluding a contract at any time during the term (‘open-house model’).
sen-info
Type: price
Description:
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.